Treatment of seborrheic dermatitis of the scalp and dandruff with a shampoo containing 1% bifonazole (Agispor shampoo)
I Shiri, Boaz Amichai
Abstract
I Shiri, Boaz Amichai
Abstract
Seborrheic dermatitis is a common chronic skin disease. We evaluated the efficacy and safety of bifonazole 1% shampoo (Agispor shampoo), a new antifungal product, in patients with seborrheic dermatitis of the scalp and dandruff. An open study evaluated the clinical efficacy of bifonazole 1% shampoo. Of 255 patients treated, 91% achieved a successful clinical outcome. The drug was well tolerated. Few side-effects, mainly mild localized itch, were reported.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Seborrheic dermatitis is a common chronic skin disease. We evaluated the efficacy and safety of bifonazole 1% shampoo (Agispor shampoo), a new antifungal product, in patients with seborrheic dermatitis of the scalp and dandruff. An open study evaluated the clinical efficacy of bifonazole 1% shampoo. Of 255 patients treated, 91% achieved a successful clinical outcome. The drug was well tolerated. Few side-effects, mainly mild localized itch, were reported.
Key concepts: Seborrheic dermatitis, Shampoo, Dandruff, Bifonazole, Dermatology, Medicine, Scalp, Malassezia